New shot hopes to help COPD patients breathe easier
Disease control
Not yet recruiting
This study tests an experimental drug called XKH001 for people with moderate to severe COPD, a long-term lung disease. The trial will check if the injection improves lung function and is safe over 24 to 48 weeks. About 75 adults aged 40-80 will take part, receiving either the dru…
Phase: PHASE2 • Sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC